Financhill
Sell
39

PUMSY Quote, Financials, Valuation and Earnings

Last price:
$4.71
Seasonality move :
-12.08%
Day range:
$4.58 - $4.73
52-week range:
$3.62 - $5.66
Dividend yield:
1.89%
P/E ratio:
25.24x
P/S ratio:
0.76x
P/B ratio:
2.43x
Volume:
141.7K
Avg. volume:
734.7K
1-year change:
-18.65%
Market cap:
$7B
Revenue:
$9.3B
EPS (TTM):
$0.19
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $6.2B $6B $8.1B $8.9B $9.3B
Revenue Growth (YoY) 12.22% -2.95% 34.7% 10.87% 4.31%
 
Cost of Revenues $3.2B $3.2B $4.2B $4.8B $5B
Gross Profit $3B $2.8B $3.9B $4.1B $4.3B
Gross Profit Margin 48.82% 46.96% 47.87% 46.1% 46.35%
 
R&D Expenses $69.1M $64.6M $73M $86.7M $96.4M
Selling, General & Admin $2.5B $2.5B $3.2B $3.4B $3.6B
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.5B $2.6B $3.2B $3.4B $3.6B
Operating Income $488.2M $238.5M $659.3M $675.5M $672.8M
 
Net Interest Expenses $37.1M $49.1M $50.5M $62.1M $54.5M
EBT. Incl. Unusual Items $467.5M $185.4M $597.9M $581.8M $517.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $121.6M $44.8M $152M $134.4M $127.5M
Net Income to Company $467.5M $185.4M $597.9M $581.8M $517.8M
 
Minority Interest in Earnings -$52.2M -$50.5M -$79.5M -$74.8M -$60.3M
Net Income to Common Excl Extra Items $293.8M $90.1M $366.3M $372.8M $330.1M
 
Basic EPS (Cont. Ops) $0.20 $0.06 $0.24 $0.25 $0.22
Diluted EPS (Cont. Ops) $0.20 $0.06 $0.24 $0.25 $0.22
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $796.9M $609.8M $1B $1.1B $1.1B
EBIT $521M $274.3M $650.4M $712.3M $688.9M
 
Revenue (Reported) $6.2B $6B $8.1B $8.9B $9.3B
Operating Income (Reported) $488.2M $238.5M $659.3M $675.5M $672.8M
Operating Income (Adjusted) $521M $274.3M $650.4M $712.3M $688.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $1.9B $2.2B $2.4B $2.5B $2.5B
Revenue Growth (YoY) 12.7% 21.01% 5.85% 6.09% 0.89%
 
Cost of Revenues $980.4M $1.2B $1.3B $1.3B $1.3B
Gross Profit $871.2M $1.1B $1.1B $1.2B $1.2B
Gross Profit Margin 47.05% 47.4% 46.82% 47.11% 47.9%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $649.5M $792.2M $850.9M $928.1M $955.2M
Operating Income $221.7M $269.9M $259.6M $257.3M $260.7M
 
Net Interest Expenses $20.6M $12.4M $37.2M $49.5M $51.4M
EBT. Incl. Unusual Items $201M $257.4M $222.4M $207.8M $209.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $52.3M $65.7M $56.7M $52.2M $52.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$15.9M -$22.2M -$18.2M -$12.3M -$16.1M
Net Income to Common Excl Extra Items $132.8M $169.5M $147.5M $143.4M $140.6M
 
Basic EPS (Cont. Ops) $0.09 $0.11 $0.10 $0.10 $0.09
Diluted EPS (Cont. Ops) $0.09 $0.11 $0.10 $0.10 $0.09
Weighted Average Basic Share $1.5B $1.5B $1.5B $1.5B $1.5B
Weighted Average Diluted Share $1.5B $1.5B $1.5B $1.5B $1.5B
 
EBITDA $221.7M $269.9M $259.6M $257.3M $260.7M
EBIT $221.7M $269.9M $259.6M $257.3M $260.7M
 
Revenue (Reported) $1.9B $2.2B $2.4B $2.5B $2.5B
Operating Income (Reported) $221.7M $269.9M $259.6M $257.3M $260.7M
Operating Income (Adjusted) $221.7M $269.9M $259.6M $257.3M $260.7M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $5.8B $7.8B $8.7B $9.4B $9.2B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.1B $4.1B $4.6B $5.1B $4.9B
Gross Profit $2.7B $3.7B $4.1B $4.3B $4.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $2.5B $3.1B $3.4B $3.7B $3.7B
Operating Income $230.3M $662.2M $710M $612.8M $661M
 
Net Interest Expenses $61.9M $43.1M $78M $78.9M $98.4M
EBT. Incl. Unusual Items $184.6M $614.7M $621.3M $503.5M $462.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $45.7M $153.5M $158M $112.4M $113.6M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$51.8M -$71.9M -$80.9M -$60.2M -$67.5M
Net Income to Common Excl Extra Items $87.2M $389.3M $382.5M $330.8M $281.5M
 
Basic EPS (Cont. Ops) $0.06 $0.26 $0.26 $0.22 $0.19
Diluted EPS (Cont. Ops) $0.06 $0.26 $0.26 $0.22 $0.19
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $262.8M $699.6M $701.5M $648.5M $676.9M
EBIT $262.8M $699.6M $701.5M $648.5M $676.9M
 
Revenue (Reported) $5.8B $7.8B $8.7B $9.4B $9.2B
Operating Income (Reported) $230.3M $662.2M $710M $612.8M $661M
Operating Income (Adjusted) $262.8M $699.6M $701.5M $648.5M $676.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $4.2B $6B $6.6B $7.2B $7.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.2B $3.1B $3.5B $3.9B $3.7B
Gross Profit $2B $2.9B $3.1B $3.3B $3.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.8B $2.3B $2.5B $2.7B $2.8B
Operating Income $173.7M $587.2M $635.6M $571.5M $559.4M
 
Net Interest Expenses $43.9M $38.5M $65.5M $83M $126.3M
EBT. Incl. Unusual Items $129.9M $549M $569.9M $488.7M $433.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $33.8M $140M $145.3M $122.2M $108.2M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -$28.6M -$49.2M -$51.1M -$37M -$44.3M
Net Income to Common Excl Extra Items $67.5M $359.8M $373.5M $329.4M $280.5M
 
Basic EPS (Cont. Ops) $0.04 $0.24 $0.25 $0.22 $0.19
Diluted EPS (Cont. Ops) $0.04 $0.24 $0.25 $0.22 $0.19
Weighted Average Basic Share $4.5B $4.5B $4.5B $4.5B $4.5B
Weighted Average Diluted Share $4.5B $4.5B $4.5B $4.5B $4.5B
 
EBITDA $173.7M $587.2M $635.6M $571.5M $559.4M
EBIT $173.7M $587.2M $635.6M $571.5M $559.4M
 
Revenue (Reported) $4.2B $6B $6.6B $7.2B $7.1B
Operating Income (Reported) $173.7M $587.2M $635.6M $571.5M $559.4M
Operating Income (Adjusted) $173.7M $587.2M $635.6M $571.5M $559.4M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $580.4M $806.7M $857.7M $496.6M $611.2M
Short Term Investments $35.2M $36M $34.2M $23.2M $50.4M
Accounts Receivable, Net $685.2M $763.8M $960.1M $1.1B $1.2B
Inventory $1.2B $1.4B $1.7B $2.4B $2B
Prepaid Expenses $70.7M $62M $131.5M $95.9M $111.9M
Other Current Assets -- -- -$113.2K -$107.2K -$110.5K
Total Current Assets $2.8B $3.2B $4B $4.5B $4.3B
 
Property Plant And Equipment $1.2B $1.6B $1.6B $1.8B $2B
Long-Term Investments -- -- -- -- --
Goodwill $279.7M $297M $277.1M $260.3M $264.2M
Other Intangibles $229.5M $248.5M $257.2M $282.9M $322.6M
Other Long-Term Assets $21.7M $8.5M $10.2M $9.5M $28.3M
Total Assets $4.9B $5.8B $6.5B $7.3B $7.3B
 
Accounts Payable $945.1M $1.2B $1.3B $1.9B $1.7B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $162.2M $192.5M $195.1M $214.7M $234.8M
Other Current Liabilities $421.2M $464.7M $621.9M $663.6M $545.5M
Total Current Liabilities $1.7B $2.3B $2.5B $3B $2.8B
 
Long-Term Debt -- -- -- $269.7M $471M
Capital Leases -- -- -- -- --
Total Liabilities $2.8B $3.6B $3.9B $4.5B $4.5B
 
Common Stock $168.9M $185.5M $170.7M $161.7M $166.7M
Other Common Equity Adj -- -- -- -- --
Common Equity $2.1B $2.1B $2.5B $2.7B $2.8B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $52.3M $51M $73.8M $72M $31.9M
Total Equity $2.2B $2.2B $2.6B $2.7B $2.9B
 
Total Liabilities and Equity $4.9B $5.8B $6.5B $7.3B $7.3B
Cash and Short Terms $615.5M $842.8M $891.8M $519.8M $661.6M
Total Debt -- $149.3M $77.6M $351.1M $632.3M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $447.2M $869.2M $400M $304.8M $280.9M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $894M $1.2B $1.3B $1.5B $1.7B
Inventory $1.4B $1.6B $2.3B $2B $2B
Prepaid Expenses -- -- -- -- --
Other Current Assets $239.6M $329.1M $678.8M $568.1M $601.2M
Total Current Assets $3B $4B $4.7B $4.4B $4.6B
 
Property Plant And Equipment $994.7M $1.1B $1B $1.1B $1.2B
Long-Term Investments -- -- -- -- --
Goodwill -- -- -- -- --
Other Intangibles -- -- -- -- --
Other Long-Term Assets $1.1B $1.2B $1.2B $1.4B $1.6B
Total Assets $5.4B $6.6B $7.1B $7.3B $7.7B
 
Accounts Payable $1.1B $1.4B $1.8B $1.3B $1.4B
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $181.3M $192.5M $196.8M $215.9M $232.5M
Other Current Liabilities $663M $853.1M $872.5M $810.7M $769.1M
Total Current Liabilities $2.1B $2.4B $3B $2.7B $3.2B
 
Long-Term Debt -- -- -- -- $400M
Capital Leases -- -- -- -- --
Total Liabilities $3.3B $4B $4.3B $4.3B $4.8B
 
Common Stock -- -- -- -- --
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.1B $2.6B $2.8B $2.9B $2.9B
 
Total Liabilities and Equity $5.4B $6.6B $7.1B $7.3B $7.7B
Cash and Short Terms $447.2M $869.2M $400M $304.8M $280.9M
Total Debt -- -- -- -- $1.1B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $467.5M $185.4M $597.9M $581.8M $517.8M
Depreciation & Amoritzation $275.8M $335.5M $361.8M $378.3M $387M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -$78.1M -$57.1M -$335.1M -$220.8M -$166.1M
Change in Inventories -$211.4M -$125.3M -$360M -$787.8M $381.2M
Cash From Operations $614.4M $481.4M $544.4M $441.1M $707.6M
 
Capital Expenditures $244.5M $172.4M $239.5M $278M $325.2M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$244.8M -$166.2M -$217.5M -$253.9M -$308.1M
 
Dividends Paid (Ex Special Dividend) -$58.5M -- -$28.3M -$113.6M -$132.9M
Special Dividend Paid
Long-Term Debt Issued -- -- $278M $18.9M $324.3M
Long-Term Debt Repaid -$7.9M -$20.9M -$81M -$73.3M -$64M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$11.8M $128.7M -$63.3M -- -$108.3K
Cash From Financing -$305.5M -$147.5M -$194M -$502.4M -$300M
 
Beginning Cash (CF) $519.1M $591.7M $776M $798.9M $501.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $64M $167.6M $132.9M -$315.2M $99.5M
Ending Cash (CF) $580M $749.1M $896.3M $488.4M $598.6M
 
Levered Free Cash Flow $369.9M $308.9M $304.9M $163.1M $382.4M
Period Ending 2011-12-31 2012-12-31 2013-12-31 2014-12-31 2015-12-31
Net Income to Stockholders $49.4M -$65.3M -$168.3M $13.3M $10.5M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $243.7M $242.3M $192M $226M $183.8M
 
Capital Expenditures $36.1M $36.6M $29.2M $33.2M $27M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$33.8M -$36.7M -$27.1M -$22M -$17.7M
 
Dividends Paid (Ex Special Dividend) $510.5K -$1.1M -$19.4K -$34.5K $12.3K
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -$47.8M -$53M -$123.7M
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock $506.7K -- -- -- --
Other Financing Activities $7.4M -$27.5M -$16.7M -$15.3M -$21.4M
Cash From Financing $1.3M -$16.3M -$81.5M -$82.6M -$85.4M
 
Beginning Cash (CF) $409.2M $327.8M $446.3M $406.5M $299.6M
Foreign Exchange Rate Adjustment $14.1M -$9.7M -$12.6M $4.1M -$3.6M
Additions / Reductions $211.1M $189.4M $83.4M $121.4M $80.7M
Ending Cash (CF) $624.9M $523.6M $518.1M $533.9M $376M
 
Levered Free Cash Flow $207.6M $205.7M $162.8M $192.8M $156.8M
Period Ending 2012-09-30 2013-09-30 2014-09-30 2015-09-30 2016-09-30
Net Income to Stockholders $259.1M $174.4M -$19.6M $97.1M --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations $202.8M $195.5M $134M $1.1M --
 
Capital Expenditures $103.9M $81.4M $92.5M $93.9M $27M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$209.1M -$116M -$120.8M -$72.8M --
 
Dividends Paid (Ex Special Dividend) -$36.9M -$11M -$10M -$8.4M $12.3K
Special Dividend Paid
Long-Term Debt Issued -- $53M $5.2M $78.8M --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities $34.5M -$10.7M -$4.5M $6.3M --
Cash From Financing -$9.7M $32.3M -$47M $34.9M --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$16M $111.8M -$33.8M -$36.8M --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $98.9M $114.1M $41.5M -$92.8M --
Period Ending 2020-12-23 2021-12-23 2022-12-23 2023-12-23
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock